secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2022-10-11T23:59:59+00:00
Accession:  0001493152-22-028136
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics prices $5.1M public offering of 3.78M units at $1.35/unit
------------------------------------------------------------------------

- Gross proceeds $5.1M from sale of 3,777,778 units; net proceeds estimated ~$4.454M.
- Each unit: 1 common share plus Series A ($1.62), B ($1.35), C ($2.16) warrants, 5-year term.
- Series C warrant cashless exercise trigger: 15 days after issuance or $10M common stock volume traded.
- Underwriters granted 45-day over-allotment option for up to 566,666 additional shares/warrants.
- Closing expected October 12, 2022; WallachBeth Capital acting as sole book-running manager.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315222028136/0001493152-22-028136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315222028136/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-028136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer